BioSpace News Archive

BioMidwest

The Future Looks Brighter Thanks to Prospective Sustainability Innovations for Procter & Gamble’s Tide®

Procter & Gamble (P&G) announced presentations given on new research into sustainability innovations for its Tide® laundry detergent.

June 11, 2018
·
4 min read
Drug Development

NeuroRx, Inc. Completes Phase 2b/3 Feasibility Enrollment for First Glx-Targeted Oral Drug Targeting Suicidal Bipolar Depression

NRX-101 was awarded FAST TRACK designation by the FDA in August 2017 as an experimental agent for the treatment of Severed Bipolar Depression with Acute Suicidal Ideation or Behavior.

June 11, 2018
·
7 min read
RSP Systems Secures Series B Funding to Drive its Non-Invasive Glucose Monitor

RSP Systems A/S, the non-invasive diagnostics company, announces that it has completed the first closing of a Series B funding round amounting to €6.5 million.

June 11, 2018
·
1 min read
Business

Matt Pammer appointed as Prime Therapeutics’ Chief Information Officer

Prime Therapeutics LLC has named Matt Pammer chief information officer (CIO) and senior vice president.

June 11, 2018
·
2 min read
Pharm Country

Brown University and the Cardinal Health Foundation Host Opioid Management Curriculum Development Symposium

Conference to develop a curriculum that teaches medical students across the country

June 11, 2018
·
6 min read
Sinovac Biotech Relaunches Company Website

Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), today announced that the company has relaunched its website, at www.sinovacbio.com.

June 11, 2018
·
2 min read
Genetown

Can Your DNA Predict Opioid Addiction? New Research Partnership Between Bentley University and Gravity Diagnostics Will Explore the Genetic Link to Opioid Abuse

Bentley University and Gravity Diagnostics have announced a partnership to conduct research that could inform doctors prescribing pain medication how likely a patient is to become addicted and predict how those already addicted to opioids will respond to certain treatments.

June 11, 2018
·
4 min read
Drug Development

FDA Approves Addition Of Positive Overall Survival Data From Phase 3 ASPIRE Trial To KYPROLIS® (carfilzomib) Label

KYPROLIS, Lenalidomide and Dexamethasone Extended Median Overall Survival in Relapsed or Refractory Multiple Myeloma Patients to 48 Months KYPROLIS is the First and Only Treatment to Demonstrate Overall Survival Benefits in Two Phase 3 Studies in Relapsed or Refractory Multiple Myeloma

June 11, 2018
·
19 min read
Policy

Zecotek’s Working Closely With European Healthcare OEM as It Prepares to Open Its LFS Crystal Manufacturing Facility

Zecotek Photonics Inc. is pleased to announce that it is working closely with a tier 1, healthcare OEM based in Europe to assure quality control protocols within its new Lutetium Fine Silicate (LFS) scintillation crystals manufacturing facility in Shanghai.

June 11, 2018
·
5 min read
Business

Genpact Accelerates Strategy to Establish New Industry Standard for Pharmacovigilance Using AI and Machine Learning Technologies

Acquisition of Commonwealth Informatics further strengthens Genpact’s Pharmacovigilance AI capabilities to help transform drug safety

June 11, 2018
·
6 min read